STOCK TITAN

STAAR Surgical (STAA) exec's 6,599-share award, ownership corrected

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

STAAR SURGICAL CO (STAA) reported that Chief Development Officer Magda Michna settled and exercised performance-based equity awards on August 14, 2026. A third tranche of 5,499 performance stock units from her 2025 annual equity grant and 1,100 units from a promotion-related grant were settled into common stock, totaling 6,599 shares acquired. Of these, 2,797 shares were withheld to satisfy taxes and an additional 559 shares were delivered or withheld for payment of exercise price or tax liability. The company also corrected prior Form 4 filings to reflect lower historical beneficial ownership values.

Positive

  • None.

Negative

  • None.
Insider Michna Magda
Role Chief Development Officer
Type Security Shares Price Value
Exercise Performance Stock Units F3 5,499 $0.00 $0.00
Exercise Performance Stock Units F4 1,100 $0.00 $0.00
Exercise Common Stock F1 5,499 $0.00 $0.00
Tax Withholding Common Stock F2 2,797 $26.18 $73K
Exercise Price or Tax Liability Common Stock 559 $26.18 $15K
Exercise Common Stock 1,100 $26.18 $29K
Holdings After Transaction: Performance Stock Units — 6,599 shares (Direct); Common Stock — 41,343 shares (Direct)
Footnotes (4)
  1. F1. Due to clerical errors, the Reporting Person's prior Form-4 filed with the Securities and Exchange Commission on May 12, 2026 incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares and the Reporting Person's prior Form 4 filed with the SEC on May 19, 2026 incorrectly reported this value as 46,026 when the Reporting Person beneficially owned 38.100. The values have been corrected herein.
  2. F2. On August 14, 2026, the third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 2,797 shares were withheld to satisfy taxes.
  3. F3. Represents the settlement of the third tranche of 5,499 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her annual equity grant vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
  4. F4. Represents the settlement of the third tranche of of 1,100 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her promotion to Chief Development Officer vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
PSUs settled (annual grant tranche) 5,499 units Third tranche of PSUs under the 2025 PSU Program tied to annual equity grant
PSUs settled (promotion grant tranche) 1,100 units Third tranche of PSUs under the 2025 PSU Program tied to promotion to Chief Development Officer
Total shares acquired from PSU settlement 6,599 shares Common stock received upon settlement and exercise/conversion of PSUs on August 14, 2026
Shares withheld to satisfy taxes 2,797 shares Withholding from the 5,499-PSU tranche under the 2025 PSU Program
Additional shares delivered/withheld for payment 559 shares Code F transaction for payment of exercise price or tax liability
Per-share value used for F-code transactions $26.18 per share Applied to 2,797- and 559-share tax or exercise-price-related dispositions
Expiration date of PSU awards December 31, 2027 Expiration date listed for the performance stock unit awards involved in these settlements
Performance Stock Units financial
"third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
2025 Performance Stock Award Program financial
"awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program"
Rule 16b-3(d) regulatory
"The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
beneficially owned financial
"incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
withheld to satisfy taxes financial
"of which 2,797 shares were withheld to satisfy taxes"

FAQ

What insider equity transactions did STAA executive Magda Michna report on August 14, 2026?

Magda Michna reported settlement and exercise of performance stock units into common stock on August 14, 2026. A total of 6,599 shares of STAAR SURGICAL CO common stock were acquired upon vesting of 2025 Performance Stock Award Program tranches tied to annual and promotion-related grants.

How many STAAR SURGICAL (STAA) shares were acquired from vested performance stock units?

A total of 6,599 shares of STAA common stock were acquired from vested performance stock units. This includes 5,499 PSUs from the 2025 annual equity grant and 1,100 PSUs from a promotion-related grant, each settled after Compensation Committee certification of performance goals.

Were the August 14, 2026 STAA insider transactions under a Rule 10b5-1 trading plan?

The filing indicates the Rule 10b5-1 checkbox is not affirmatively marked, and no footnote describes a pre-arranged trading plan. The reported activity concerns PSU vesting and related tax or exercise-price share withholdings rather than open-market purchases or sales.

Did STAAR SURGICAL (STAA) correct any prior share ownership figures in this Form 4?

Yes. A footnote states prior Forms 4 filed in May 2026 overstated beneficial ownership. Correct values are given as 28,008 shares for one date and 38.100 for another, with this filing stating that those holdings figures have been corrected herein.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Michna Magda

(Last)(First)(Middle)
25510 COMMERCENTRE DRIVE

(Street)
LAKE FOREST CALIFORNIA 92630

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Development Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/14/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/14/2026M5,499A$043,599(1)D
Common Stock08/14/2026F2,797(2)D$26.1840,802D
Common Stock08/14/2026F559D$26.1840,243D
Common Stock08/14/2026M1,100A$26.1841,343D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units$008/14/2026M5,499 (3)12/31/2027Common Stock5,499$05,499D
Performance Stock Units$008/14/2026M1,100 (4)12/31/2027Common Stock1,100$01,100D
Explanation of Responses:
1. Due to clerical errors, the Reporting Person's prior Form-4 filed with the Securities and Exchange Commission on May 12, 2026 incorrectly reported this value as 32,691 shares when the Reporting Person beneficially owned 28,008 shares and the Reporting Person's prior Form 4 filed with the SEC on May 19, 2026 incorrectly reported this value as 46,026 when the Reporting Person beneficially owned 38.100. The values have been corrected herein.
2. On August 14, 2026, the third tranche of 5,499 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 2,797 shares were withheld to satisfy taxes.
3. Represents the settlement of the third tranche of 5,499 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her annual equity grant vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
4. Represents the settlement of the third tranche of of 1,100 PSUs awarded to the Reporting Person under the Issuer's 2025 PSU Program in connection with her promotion to Chief Development Officer vested. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
/s/ Magda Michna08/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)